You are here
Award Data
The Award database is continually updated throughout the year. As a result, data for FY22 is not expected to be complete until September, 2023.
Download all SBIR.gov award data either with award abstracts (290MB)
or without award abstracts (65MB).
A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.
-
An in vitro model for screening penetration of ocular drug products
SBC: CFD RESEARCH CORPORATION Topic: NEIProject Summary/Abstract: The overall objective of this study is to develop a novel, predictive in vitro platform for studying physiological responses of the cellular layers of the anterior eye for therapeutics. Current in vitro models mostly rely on a single cellular architecture of the corneal epithelium and do not mimic the in vivo physiological relevance of cell-cell and cell-ECM interactions. ...
SBIR Phase I 2022 Department of Health and Human ServicesNational Institutes of Health -
APTU Upgrade that Extends Operational Run Time and Test Regimes
SBC: CFD RESEARCH CORPORATION Topic: AF161024The run time of the Aerodynamic and Propulsion Test Unit (APTU) facility operated by the Air Force Test Center (AFTC) requires extension to approximately 1000 seconds in order to support hypersonic system ground test and evaluation over an entire mission profile in a similar fashion has the Space and Missile Defense Command (SMDC) Hot Air Tunnel (HAT) effort. CFD Research is leveraging prior i ...
SBIR Phase II 2022 Department of DefenseAir Force -
Mobile Pilot-Controller and Drone Detection System
SBC: DRONE GO HOME, LLC Topic: AF193DCSO1The AeroDefense drone and pilot (controller) detection, location and alert system operates on a physical signal level. The system scans 400/900 MHz and 2.4/5.8 GHz for Radio Frequency (RF) signals with similar power, frequency-hop and other physical characteristics to those used by drones and their ground station controllers. If the drone signature is in the AeroDefense system database, manufactur ...
SBIR Phase II 2020 Department of DefenseAir Force -
Open Call for Innovative Defense-Related Dual-Purpose Technologies/Solutions with a Clear Air Force Stakeholder Need
SBC: FALKONRY INC. Topic: AF191005The Air Force (AF) has yet to leverage broad and operator-based machine learning (ML) into their maintenance, mission, or operational environments. Falkonry’s commercially demonstrated “Data Scientist in a Box,� is a pre-packaged operational ML solution that empowers teams with pattern discovery, predictive analytics, and explanation to improve uptime, performance, quality and ...
SBIR Phase I 2019 Department of DefenseAir Force -
Open Call for Innovative Defense-Related Dual-Purpose Technologies/Solutions with a Clear Air Force Stakeholder Need
SBC: FALKONRY INC. Topic: AF191005Falkonry LRS is your “Data Scientist in a Box,â€ï¿½ pre-packaged operational machine learning (ML) empowers your teams with pattern discovery, predictive analytics and explanation to improve uptime, performance, quality and safety. Falkonry believes its AI-enabled LRS could add significant value to the processing of electronic intelligence (ELINT) data, at scale and for significantly l ...
SBIR Phase II 2019 Department of DefenseAir Force -
High-Throughput Low Cost Production of Chromatin-Immunoprecipitation-Grade Antib
SBC: NECTAGEN INC Topic: NHGRIDESCRIPTION (provided by applicant): Identifying the regulatory regions of the genome is critical for understanding the regulatory networks underlying human development and disease. Chromatin immunoprecipitation (ChIP) coupled with microarray (ChIP-chip) or sequencing (ChIP- seq) is a widely used technique for understanding the genome-wide binding pattern of regulatory proteins. A key bottleneck ...
SBIR Phase I 2010 Department of Health and Human ServicesNational Institutes of Health -
DEVELOPMENT OF ALTERNATIVE AFFINITY CAPTURE REAGENTS FOR CANCE
SBC: NECTAGEN INC Topic: NCIMany of the antibodies produced for cancer research are poorly characterized, exhibit suboptimal affinity or selectivity, and are time-consuming and expensive to produce. Alternative affinity capture reagents are therefore needed as reproducible, highly characterized, rapid, and cost-effective substitutes for monoclonal antibodies. As a platform for creating affinity capture reagents, Aptakon has ...
SBIR Phase I 2010 Department of Health and Human ServicesNational Institutes of Health -
SBIR TOPIC 294 PHASE I- DEVELOPMENT OF GLYCOSYLATION- SPECIFIC RESEARCH
SBC: NECTAGEN INC Topic: NCIThe function of many cancer related proteins is modulated by modifications such as phosphorylation and glycosylation. The development of antibodies that recognize site-specific phosphorylation has vastly improved our understanding of signal transductionand cancer cell physiology and regulation. However, almost no available antibodies recognize site specific glycosylation, and in particular, N-a ...
SBIR Phase I 2011 Department of Health and Human ServicesNational Institutes of Health -
Generation of High Resolution Antibody Mimetics to Improve the Visualization of Subcellular Structures by Super Resolution Microscopy
SBC: NECTAGEN INC Topic: 400The goal of this Phase I SBIR project is to develop a set of high resolution antibody mimeticsnanoCLAMPsoptimized for super resolution imaging of a broad range of subcellular structuresAdvances in super resolution microscopy have enabled the achievement of resolutions well below the diffraction limit with current techniques now approachingnmFor immunostainingthenm size of antibody complexes now li ...
SBIR Phase I 2018 Department of Health and Human ServicesNational Institutes of Health -
Affinity reagents for the sub-fractionation of specific exosomal populations
SBC: NECTAGEN INC Topic: 400The goal of this Phase I SBIR project is to develop affinity reagents useful for the sub fractionation of specific exosomal populationsBecause exosomal makeup and cargo reflect the typedevelopmental stageand the disease state of the cells they are shed fromthey are attractive targets for non invasive diagnosticsExosomes are also being investigated for therapeutic applications such as vaccines and ...
SBIR Phase I 2018 Department of Health and Human ServicesNational Institutes of Health